Taipei, June 1 (CNA) Academia Sinica and vaccine developer Moderna Inc. have agreed to jointly develop messenger ribonucleic acid (mRNA) technology and cultivate research talent in Taiwan under a five-year strategic partnership announced Thursday.
Taipei, Feb. 11 (CNA) A team of researchers from Taiwan's Academia Sinica has developed a series of next-generation vaccines that early results show could be highly effective against the Omicron variant of COVID-19 as well as new mutations of the disease.